Indacaterol Maleate

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
50 mg	3-5days	$213.00	Visible after login	- +
100 mg	3-5days	$340.00	Visible after login	- +
250 mg	3-5days	$575.00	Visible after login	- +

Size

Availability

Price(USD)

VIP Price (USD)

Quantity

50 mg

3-5days

$213.00

Visible after login

- +

100 mg

3-5days

$340.00

Visible after login

- +

250 mg

3-5days

$575.00

Visible after login

- +

Product Overview

Product Name	Indacaterol Maleate
CAS	753498-25-8
Formula	C28H32N2O7
MW	508.56
Appearance	White to off-white powder
Storage condition	Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Product details

Indacaterol Maleate (formerly known as QAB149; QAB-149; Onbrez Breezhale; arcapta neohaler; Onbrez), the maleate salt of indacaterol, is an approved anti-COPD (chronic obstructive pulmonary disease) drug acting as an ultra-long-acting β-adrenoceptor agonist developed by Novartis. β-adrenoceptor is activated with a pKi of 7.36 in. The FDA approved indacaterol in 2009 to treat chronic obstructive pulmonary disease (COPD). Using a dry powder inhaler, the aerosol formulation is administered. When Chinese hamster ovary cells are transfected with human β2 adrenoceptors and have a pEC50 of 8.06, indacaterol inhibits the production of cAMP.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CL2534A

Indacaterol Maleate

753498-25-8 98+%